Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
  • WIIM
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
9 minute read
  • Commodities
  • Earnings
  • Economics
  • Federal Reserve
  • General
  • Global
  • Guidance
  • Markets
  • News
  • Retail Sales
  • Small Cap
  • Tech

Underwhelming: Tepid Jobs Data Could Add New Variable To Fed Policy Equation

By JJ Kinahan
Today, 5:42 AM
That hissing noise you hear is the air being let out of the market’s tires after an epically disappointing August jobs report. The Delta variant seems to be sinking its teeth into the economy, taking a massive bite into the jobs picture. 

AVGO

Read More
3 minute read
  • Biotech
  • Legal
  • News
  • Penny Stocks
  • Small Cap

The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself

By Shanthi Rexaline
Today, 5:42 AM
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2)

ABT

Read More
5 minute read
  • Biotech
  • Earnings
  • FDA
  • News
  • Penny Stocks
  • Small Cap

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab

By Shanthi Rexaline
Today, 5:42 AM
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1)

ABBV

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Morgan Stanley Maintains Equal-Weight on Quest Diagnostics, Raises Price Target to $165

By Benzinga Newsdesk
Today, 5:42 AM
Morgan Stanley analyst Craig Hettenbach maintains Quest Diagnostics (NYSE:DGX) with a Equal-Weight and raises the price target from $136 to $165.

DGX

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Mizuho Maintains Buy on Quest Diagnostics, Raises Price Target to $166

By Benzinga Newsdesk
Today, 5:42 AM
Mizuho analyst Ann Hynes maintains Quest Diagnostics (NYSE:DGX) with a Buy and raises the price target from $158 to $166.

DGX

Read More
6 minute read
  • Biotech
  • Earnings
  • FDA
  • General
  • News
  • Penny Stocks
  • Small Cap
  • Top Stories

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios’ Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline

By Shanthi Rexaline
Today, 5:42 AM
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17)

ABBV

Read More
1 minute read
  • FDA
  • News

Quest Diagnostics Media Statement about COVID-19 Testing

By Benzinga Newsdesk
Today, 5:42 AM
https://newsroom.questdiagnostics.com/COVIDTestingUpdates

DGX

Read More
5 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Trading Ideas

Stocks That Hit 52-Week Highs On Tuesday

By Benzinga Insights
Today, 5:42 AM
    Before 10 a.m. ET on Tuesday, 55 companies set new 52-week highs.

AAPL

Read More
8 minute read
  • Biotech
  • Earnings
  • FDA
  • General
  • News
  • Penny Stocks
  • Small Cap

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business

By Shanthi Rexaline
Today, 5:42 AM
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16)

ABSI

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Credit Suisse Maintains Neutral on Quest Diagnostics, Raises Price Target to $150

By Benzinga Newsdesk
Today, 5:42 AM
Credit Suisse maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $135 to $150.

DGX

Posts navigation

Previous 1 … 9 10 11 … 13 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service